Synthesis of Yellow-Fluorescent Carbon Nano-dots by Microplasma for Imaging and Photocatalytic Inactivation of Cancer Cells

In recent years, multifunctional nanoparticles with combined diagnostic and therapeutic functions show great promise in nanomedicine. In this study, we report the environmentally friendly synthesis of fluorescent carbon nano-dots such as carbon quantum dots (CQDs) by microplasma using o-phenylenediamine. The produced CQDs exhibited a wide absorption peaks at 380–500 nm and emitted bright yellow fluorescence with a peak at 550 nm. The CQDs were rapidly taken up by HeLa cancer cells. When excited under blue light, a bright yellow fluorescence signal and intense reactive oxygen species (ROS) were efficiently produced, enabling simultaneous fluorescent cancer cell imaging and photodynamic inactivation, with a 40% decrease in relative cell viability. Furthermore, about 98% cells were active after the incubation with 400 μg mL−1 CQDs in the dark, which revealed the excellent biocompatibility of CQDs. Hence, the newly prepared CQDs are thus demonstrated to be materials which might be effective and safe to use for in vivo bioimaging and imaging-guided cancer therapy.


Introduction
Cancer remains a leading cause of death worldwide [1]. Multifunctional nanoparticles with both diagnostic and therapeutic functions have promising applications in nanomedicine. Simultaneous image-guided therapy is a new concept in cancer treatment and shows great promise with respect to the optimization of therapeutic efficiency. It can provide useful information regarding the size and location of tumors, the optimal time window for phototherapy, and therapeutic efficacy [2][3][4]. Photodynamic therapy (PDT) has been used to treat many kinds of cancers and other diseases owing to its spatiotemporal selectivity and non-invasive nature [5,6]. Ideal photosensitizers generally possess the following characteristics: (1) highly efficient generation of reactive oxygen species (ROS), (2) good biocompatibility, and (3) water solubility [7]. However, current applications of PDT are limited by the poor water solubility, instability, and sub-optimal excitation wavelengths of photosensitizers. Therefore, the generation of photosensitizer substitutes with good water solubility and biocompatibility by environmentally friendly and low-cost methods is needed.
Carbon quantum dots (CQDs) have received tremendous attention due to their unique beneficial properties, such as simple and environmentally friendly synthesis, low toxicity, remarkable biocompatibility, excellent water solubility, and light stability [8]. CQDs have potential uses in cellular imaging, biosensing, targeted drug delivery, and other biomedical applications [9][10][11][12][13]. There are two major approaches for the synthesis of carbon dots, bottom-up and top-down approaches. Top-down methods include electrochemical oxidation, laser ablation, chemical oxidation, and ultrasonic synthesis methods. Bottom-up methods consist of hydrothermal treatment, microwave synthesis, and thermal decomposition [14][15][16][17]. However, the high temperature, high pressure, and strong acids required always lead to substantial energy consumption, complicated processes, and unavoidable harm to the environment. Therefore, novel environment-friendly synthetic methods emerge as the times require. As it has been reported, CQDs can be produced within just a few minutes using a microplasma-liquid method without high temperature condition, large energy input, and laborious procedures [18][19][20]. Microplasmas supply a unique physicochemical environment to both fundamental studies and applications involving advanced materials. The chemical and electronic environments provided by the microplasmas are highly nonequilibrium and can store energy. In this environment, a large number of electrons, ions, free radicals, and other excited-ionizedactive substances can be produced [21,22]. Although o-phenylenediamine is a raw material for carbon nano-dots synthesis, it has not been used in microplasma synthesis [23][24][25].
In this study, o-phenylenediamine was used as a raw material to synthesize CQDs by microplasma treatment. The CQDs generated by this method were uniform in size (around 3.2 nm in diameter) and exhibited an emission peak at around 550 nm. We demonstrated that the newly synthesized CQDs could produce a large amount of ROS under light conditions. In vitro, CQDs could be absorbed by HeLa tumor cells and emitted yellow light under blue wavelength excitation at 420-500 nm with low toxicity. We also observed the inactivation of HeLa tumor cells under irradiation at 460 nm. These results suggest that the newly prepared CQDs might be promising materials for in vivo bioimaging, imaging-guided or targeted cancer therapy.

Characterization of CQDs
The yellow-emissive CQDs in this study are prepared in a facile and environmentally friendly manner by a microplasma method using o-phenylenediamine as the carbon precursor. Although the method of microplasma processing has been reported to be used for carbon nano-dots synthesis, there exist rare relative researches. Figure 1A  shows transmission electron microscope (TEM) images of the CQD particles. The particles produced by microplasma were cyclo-sharp or oval-shaped with an average diameter of 3.2 nm. As shown in the high-resolution image Fig. 1A (inset), the lattice distance in the CQDs is 0.21 nm, belonging to the (1,1,0) plane of graphite. The Raman spectrum shows that D mode, named as disorder induced mode, located around 1342 cm −1 and G mode centers around 1507 cm −1 , respectively, due to the result of sp 3 and sp 2 -hybridization of carbon (Fig. 1E). It is known that the intensity of D mode compared with G mode depends on the size of the graphite micro-crystals in the sample. The higher disorder of the sample leads to the higher intensity ratio of ID/IG and the smaller graphite micro-crystal. Furthermore, the D and G mode of CQD powders can also be viewed as small graphite flakes with a relatively high intensity ratio of ID/IG (0.77).
As shown in Fig. 2B-D, a C 1s analysis revealed the presence of sp 2 /sp 3 carbons (C-C/C=C, 284.8 eV), nitrous carbons (C-O/C-N, 285.9 eV), and carbonyl carbons (C=O, 287.7 eV). The N 1s band was deconvoluted into three peaks at 399.3, 400.3, and 401.7 eV, which correspond to pyrrolic N, graphitic N, and amino N, respectively. The O 1s band contained peaks at 531.6 and 533.1 eV for C-O and C=O, respectively [28,29]. Importantly, the existence of these above functional groups endowed CQDs with favorable solubility. Furthermore, the optical properties of CQDs were investigated  Fig. 1C. The prepared CQDs exhibit an excitationdependent fluorescence emission behavior. When excited at wavelengths from 400 to 500 nm, the maximum fluorescence emission peak red-shifted from 473 to 519 nm and the fluorescence intensity decreased sharply [30]. As shown in Fig. 1D, the UV-vis spectra of CQD featured a strong absorption peak in the wavelength range of 400-490 nm. The CQDs exhibited two characteristic absorption peaks at 280 and 420 nm, which referred to π-π* (aromatic C=C) and n-π* (carboxyl and/or C-N) transitions, respectively [31,32]. Therefore, these optical properties of CQDs provided feasibility for simultaneous biological imaging and photodynamic inactivation.

Bioimaging and cytotoxicity of CQDs
To assess the capability of CQDs for bioimaging and cell labeling, in vitro cellular imaging using CQDs was investigated on HeLa cells by a confocal laser scanning microscope (CLSM). Hela cells were incubated with 200 μg mL −1 CQDs for 6 h and then prepared for CLSM detection. As a result, HeLa cells showed bright yellow fluorescence evenly distributed throughout the cell (Fig. 3A). More importantly, it should be noted that low CQDs concentration of 200 μg mL −1 was enough to label Hela cells with yellow fluorescence, which further specified the possibility of CQDs in cell imaging. As it has been reported, carbon nanoparticles always exhibited strong emission only in the blue-light region, while the long-wavelength emissions were usually weak. Under UV excitation, biological tissues frequently showed blue autofluorescence and were vulnerable to receive photodamage, which seriously hinders the biological imaging analysis applications of carbon nanoparticles with shortwavelength emissions [33]. Therefore, the development of carbon nanoparticles with long-wavelength emissions was widely concerned. In the present study, the as-prepared CQDs showed bright yellow fluorescence under the excitation of a 400-450 nm light. The excited yellow fluorescence thereby might enable CQDs to be used for detection of deep-seated tumors. However, there is still a long way to go before practical applications in human cancer imaging.
Besides luminescence characteristic, high biocompatibility, and low toxicity are always required if CQDs are intended to be developed as a potential bio-labeling reagent. For biomedical applications, materials must be highly biocompatible at recommended dosages. To examine cytotoxicity, HeLa cells were treated with CQDs at final concentrations ranging from 0 to 400 μg mL −1 for 24 h. As shown in Fig. 3B, more than 95% of cells survived as determined by MTT (3-(4,5-dimethylthiazolyl-2-yl)-2,5-diphenyltetrazolium bromide) assays, which revealed that CQDs were practically non-toxic.
These data suggest that the newly generated CQDs with excited yellow fluorescence have low cytotoxicity and high biocompatibility, which facilitate their promising prospect of biological imaging.

Efficacy of Photodynamic Therapy Cancer Cell Inactivation
As shown in Fig. 3C, viability did not differ between HeLa cells treated with CQDs or blue light alone. Simultaneous treatment with CQDs and blue light markedly reduced the cell viability of Hela cells, depending on the duration of photo-exposure. After irradiation at 460 nm for 15 min, the CQDs displayed remarkable antitumor activity; the viability of HeLa cells decreased by about 40% at a concentration of 200 μg mL −1 . To further detect the effects of the excited CQDs, MTT assays were implemented to evaluate the half maximal inhibitory concentration (IC50) of excited CQDs to Hela cells. As a result, the IC50 of CQDs after being excited on Hela cells was about 427.5 μg mL −1 (95% CI 366.7-498.7 μg mL −1 ) after a 10-min irradiation and was approximately 255.1 μg mL −1 (95% CI 220.9-249.8 μg mL −1 ) after exposure to blue light for 15 min.
These results indicated that the excited CQDs could effectively kill tumor cells like some clinical anticancer drugs, such as Photofrin [34], which prompted the promising value of CQDs in imaging-guided antitumor therapy.

ROS Generation of CQDs
During PDT, cancer cells can be killed by cytotoxic ROS generated by the endocytosed photosensitizer under appropriate irradiation conditions [35,36]. ROS can inactivate target cells by apoptosis or necrosis with little side effects via PDT in several diseases [37][38][39][40]. Inspection of Fig. 4A showed that ROS reagent emits red fluorescence, indicating the generation of ROS. Moreover, the red signal of ROS was well overlapped with the fluorescence of CQDs, which means that the generation of ROS was closely associated with the uptake of CQDs by tumor cells. As shown in Fig. 4B, compared with the control and no laser irradiation groups, the experimental groups under 460 nm laser irradiation for 15 min showed obvious ROS generation. Our results indicated that CQDs could significantly promote the production of the intracellular ROS under the irradiation of 460 nm laser and had great potential for application in PDT. In principle, the CQDs can be excited from the ground state (S0 in Fig. 4C) to an excited state (Sn in Fig. 4C), and the efficiency of this process is determined by the intensity of the light source and the extinction coefficient. After solvent-mediated relaxation, CQDs remain at the lowest vibration level of the first singlet excited state. Due to the rapid vibrational relaxation following excitation, the energy of the photon emitted from the first singlet excited state (S1 in Fig. 4C) is lower than the energy of the excitation photon, resulting in a wavelength increase. Fluorescence imaging utilizes the CQDs transition from S0 to Sn to S1 [41]. The CQDs were ingested by HeLa tumor cells and emitted fluorescence when illuminated by a suitable wavelength source, thereby allowing the cells to be labeled. S1 can return to the S0 state by fluorescence or by intersystem crossing to a non-fluorescent triplet excited state (T1 in Fig. 4C) [7,42]. The fluorescent group of T1 is especially active in electron transfer reactions, generating superoxide free radicals and subsequently resulting in fluorescent group degradation. The energy from T1 transferred to molecular oxygen would produce an excited singlet oxygen oxidizing agent that is stronger than ground state molecular oxygen. The superoxide radicals and singlet oxygen, as well as other ROS, including OH and H 2 O 2 , react with nearby biological molecules to exert phototoxicity, leading to cell death. After the CQDs were taken up by HeLa cells, illumination resulted in the transfer of the singlet state to the triplet state through the intersystem, and the process of energy transfer produced ROS and ultimately led to cell death. Under the appropriate wavelength source, the CQDs undergo two types of energy transfer. Fluorescence was emitted to mark HeLa tumor cells, and HeLa cells were killed by ROS. Our experimental data revealed the good biocompatibility of the newly produced CQDs in the dark and the tumor-killing efficiency under light conditions. Hence, the CQDs could be used as a photosensitizer for tumor cells and tissues.
In addition, it is still an unsolved problem how CQDs can target tumor accurately and kill tumor cells more effectively. The existing abundance of surface functional hydrophilic groups (carboxyl, carbonyl, epoxy, hydroxyl, hydroxyl, etc.) enables carbon dots to conjugate with specific antibody which could precisely target tumors, and this requires tumor have specific biomarkers. Simultaneously, carbon dots could also serve as a tool for drug and gene delivery owing to their high surface area to volume ratio [43]. Considering the excellent biocompatibility, small size for internalization by tumor cells, being rich in surface functional moieties and the bioimaging potentials, carbon dots (include CQDs) are believed to become promising theranostic candidates for tumor therapy. However, there still exist challenges and many unresolved problems for the applications of carbon dots in nanomedicine and bioimaging. More efforts should be taken to promote the translation of carbon dot-related nanomedicine from bench to bedside in the future.

Conclusions
In summary, we synthesized photoluminescent CQDs using o-phenylenediamine by the plasma method. Excited by a blue laser, CQDs with a diameter of about 3.2 nm emitted yellow fluorescence. Raman, UV-vis, FTIR, and XPS results showed that more carbon atoms were involved in sp 2 hybridization, forming a new organic group. CQDs synthesized by the plasma method proved to be an effective probe in cell imaging experiments, and the yellow fluorescence emitted by CQDs can clearly mark HeLa cells. Moreover, the synthesized CQDs showed favorable solubility, non-toxic, and high biocompatibility, which could accelerate their capability of bioimaging. In addition, the excited CQDs could effectively kill Hela cells by ROS generation, which clearly exhibited satisfactory photodynamic cytotoxicity of CQDs in vitro and supported their applications in PDT.

Synthesis of Carbon Quantum Dots
The microplasma processing system is summarized in Additional file 1: Figure S1. A hollow stainless pipe with an inner diameter of 180 μm was connected to a highvoltage direct current power source (Tianjin Dongwen High-Voltage Supply Co., Ltd., Tianjin, China) and was kept at 2 mm above the surface of the solution. A Pt electrode (DJS-1; Shanghai INESA Scientific Instrument Co., Ltd., Shanghai, China) was connected to the cathode of the power source and immersed in the solution. Then, 400 mg of o-phenylenediamine (Shanghai, China) was dissolved in 40 mL of deionized water, and 20 mL of the o-phenylenediamine solution was added to a Petri dish and stirred using a magnetic stirrer. During microplasma treatment, argon (Ar) gas flowed through the pipe at a flow rate of 60 sccm, and the DC current was kept at 17 mA. After 10 min of plasma treatment, the brownishblack product was dialyzed using a dialysis membrane (molecular weight cutoff, 500 Da) against 2 L of deionized water for 12 h and subsequently filtered through a 0.22 μm ultrafiltration membrane. Finally, pure CQDs were obtained by freeze drying.

Characterization of the Structure, Composition, and Optical Properties of CQDs
The size and morphology of the CQDs were characterized by TEM using a JEM-2100F system (JEOL, Tokyo, Japan). Fluorescence spectroscopy was performed using a Perkin Elmer LS 55 Luminescence Spectrometer (Waltham, MA, USA). The UV/Vis absorption spectra were measured using the Varian Cary 50 UV-VIS spectrophotometer (Palo Alto, CA, USA). FTIR spectra were obtained using a Nicolet 6700 spectroscope (Thermo Scientific, Waltham, MA, USA), and Raman spectroscopy was performed using the 800 UV micro-Raman spectrometer (Invia-reflex, UK). XPS experiments were performed using an Axis Ultra DLD system (Shimadzu/ Kratos Analytical Ltd., Kyoto, Japan).

Cell Culture and Cytotoxicity Assay
HeLa cells (ATCC, Manassas, VA, USA) were cultured in Dulbecco's Modified Eagle Medium (DMEM) containing 10% FBS and 1% penicillin-streptomycin at 37 °C in a humidified 5% CO 2 atmosphere. For cytotoxicity studies of CQDs, cells were counted and seeded in 96-well plates containing 200 μL of complete medium at a density of 6000 cells per well. After 24 h of culture, cells were incubated with CQDs at concentrations of 0, 25, 50, 100, 200, and 400 μg mL −1 for another 24 h, and then, the cell viabilities were detected using MTT assays to assess the cytotoxicity of CQDs. Briefly, these solutions were replaced with 100 μL MTT test solution (0.5 mg mL −1 ) and incubated for 4 h in an incubator in the dark. The supernatant was removed and the crystals were dissolved in dimethyl sulfoxide (DMSO). Finally, the absorbance of each well was measured at 490 nm. The optical density was related to cell viability by assuming 100% viability for the control sample without CQDs.
MTT assay was also used to assess the IC50 of excited CQDs on Hela cells. Briefly, Hela cells in 96-well plate were incubated with CQDs at concentrations of 0, 6.25, 12.5, 25, 50, 100, 200, 400, 800, 1600, 3200, and 6400 μg mL −1 for 24 h in the incubator, treated with light at 460 nm for 10 min or 15 min separately, and then cultured for another 24 h. The cell viability of each well was detected using MTT assay and the data was used for IC50 evaluation.

Cell Imaging
Cells at a concentration of 2 × 10 4 mL −1 were seeded in a confocal dish (diameter = 15 mm), cultured for 24 h, and washed with PBS twice to ensure no dead cells. A CQD solution (200 μg mL −1 ; pH 7) was added and the cells were incubated for 6 h. The cells were subsequently washed with PBS three times to remove unbound CQDs and fixed with 4% paraformaldehyde. Then, the samples were observed using a CLSM (LSM510, Zeiss, Germany) with excitement at wavelengths ranging from 400 to 450 nm.

Photodynamic Therapy and ROS Measurement
To investigate antitumor effects, HeLa cells were incubated with 200 μg mL −1 CQDs for 24 h at 37 °C in the dark and treated with light at 460 nm (30 mW cm −2 ) for 5, 10, and 15 min. After 24 h of incubation, a standard MTT assay was performed to determine the relative